i
Important informations
Instagram
Portal
Donate now

Our researchers

Aucun résultat

Nicoletta Eliopoulos

Nicoletta Eliopoulos, PhD

Molecular & Regenerative Medicine

Adult stem cells, Cell therapy, Cell-based therapeutics, Gene therapy, GMP human cell handling and processing, Mesenchymal stem/stromal cells
  • Principal Investigator, Lady Davis Institute for Medical Research
  • Assistant Professor, Department of Surgery, McGill University
  • Laboratory Director, Jewish General Hospital Cell Processing Center

Contact details

(514) 340-8222 ext. 22757
nicoletta.eliopoulos@mcgill.ca

Snapshot

Nicoletta Eliopoulos’ laboratory is particularly interested in adult stem and progenitor cells for pre-clinical and clinical cell therapy and/or gene therapy studies for various diseases. We are currently exploring the use of gene-enhanced mesenchymal stem/stromal cells (MSCs) for the treatment of renal and breast cancers, as well as potential agents as pre-treatments for the MSCs for improving their beneficial effects.

Important Links :

See Nicoletta Eliopoulos' publications on PubMed

Major Research Activities

Our research program includes the pre-treatment, gene-enhancement, and therapeutic use of adult stem/progenitor cells.

 

Our primary basic research is on mesenchymal stem/stromal cells (MSCs) derived from different tissues, such as adipose tissue and bone marrow, for cell and gene therapy of various diseases. Currently funded projects include the development of novel gene-enhanced MSCs and their evaluation in renal and breast cancer models. Also, we are investigating new pre-treatment strategies for ameliorating MSCs’ effectiveness in tissue injury models.

 

In addition, we are involved in cell therapy clinical studies through our activities in the Jewish General Hospital Cell Processing Center (JGH CPC), a clinical-grade cell handling facility in the LDI committed to fostering early-phase trials testing cell-based technologies.

Recent Publications and References